Publications
37
Citations
745
Est. group size
~5
Recurring co-author estimate
Active years
12
Publishing since 2015
Typically publishes in teams of ~9 · 20% small-team papers (≤3 authors) · across 8 venues
- Preclinical Safety Evaluation of Human Lactoferrin Alpha (Effera <sup>®</sup> )
bioRxiv (Cold Spring Harbor Laboratory) · 2026
- A review of the safety evidence on recombinant human lactoferrin for use as a food ingredient
Food and Chemical Toxicology · 2024
- Digestive Profiles of Human Milk, Recombinant Human and Bovine Lactoferrin: Comparing the Retained Intact Protein and Peptide Release
Nutrients · 2024
- Workshop report: A study roadmap to evaluate the safety of recombinant human lactoferrin expressed in Komagataella phaffii intended as an ingredient in conventional foods – Recommendations of a scientific expert panel
Food and Chemical Toxicology · 2024
- Dose Range-Finding Toxicity Study in Rats With Recombinant Human Lactoferrin Produced in <i>Komagataella phaffii</i>
International Journal of Toxicology · 2024
- Evaluation of the potential food allergy risks of human lactoferrin expressed in Komagataella phaffii
Frontiers in Immunology · 2024
- Four-Week GLP Immunotoxicity Assessment of Lactoferrin Alpha Produced by <i>Komagataella phaffii</i> in Sprague-Dawley Rats
International Journal of Toxicology · 2024
- Evaluation of the potential food allergy risks of recombinant human lactoferrin expressed in <i>Komagataella phaffii</i>
bioRxiv (Cold Spring Harbor Laboratory) · 2024
- Dose range-finding toxicity study in rats with recombinant human lactoferrin produced in <i>Komagataella phaffii</i>
bioRxiv (Cold Spring Harbor Laboratory) · 2024
- 4-week GLP immunotoxicity assessment of lactoferrin alpha produced by <i>Komagataella phaffii</i> in Sprague Dawley rats
bioRxiv (Cold Spring Harbor Laboratory) · 2024
- Role of ILC2 in Viral-Induced Lung Pathogenesis
Frontiers in Immunology · 2021
- COVID-19 Modulates Inflammatory and Renal Markers That May Predict Hospital Outcomes among African American Males
Viruses · 2021
- Early-Life Respiratory Syncytial Virus Infection, Trained Immunity and Subsequent Pulmonary Diseases
Viruses · 2020
- Harnessing Cellular Immunity for Vaccination against Respiratory Viruses
Vaccines · 2020
- Early-Life RSV-Infection Alters Local and Systemic Immune Cell Populations in Neonates through TSLP Production
Deep Blue (University of Michigan) · 2019
- Mucosal Immunology×6
- Viruses×4
- bioRxiv (Cold Spring Harbor Laboratory)×4
- International Journal of Toxicology×3
- Frontiers in Immunology×2
- Wendy Fonseca
Medicine · University of Michigan
- Andrew J. Rasky
Medicine · University of Michigan
- Catherine Ptaschinski
Medicine · University of Michigan
- Octavio Ramilo
Medicine · The Ohio State University
- Asunción Mejías
Medicine · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 25, 2026.
Claim or correct this profile